AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
129 hedge funds and large institutions have $332M invested in Aerie Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $522M → $332M (-$190M)
Holders
129
Holding in Top 10
–
Calls
$842K
Puts
$211K
Top Buyers
| 1 | +$16.7M | |
| 2 | +$12.7M | |
| 3 | +$12.1M | |
| 4 |
Millennium Management
New York
|
+$6.25M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.2M |
Top Sellers
| 1 | -$9.93M | |
| 2 | -$7.68M | |
| 3 | -$7.51M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.99M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$4.55M |